Demystifying BOLD fMRI Data

What does blood oxygen level–dependent functional magnetic resonance imaging actually tell us about brain activity?

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

BOLD signal in no task (“resting state”) fMRIYOUTUBE, ZEUS CHIRIPAThe relevance and reliability of blood oxygen level-dependent functional magnetic resonance imaging (BOLD fMRI) data have been hotly debated for years, not least because it is still unclear what aspects of brain activity the technique is picking up. “In many ways, this would seem to be an unacceptable method for neuroscience,” said Ed Bullmore from the University of Cambridge, at a Royal Society-organized gathering of neuroscients late last month. “But if you’re interested in humans, there isn’t much of a choice.” Bullmore and colleagues had convened in Buckinghamshire, U.K., to discuss what, exactly, BOLD fMRI results can tell us.

“What we do know, of course, is what MRI measures,” said Robert Turner, director emeritus of the Max Planck Institute for Human Cognitive and Brain Sciences in Leipzig, Germany. MRI measures the magnetization of hydrogen protons in water molecules excited by pulses of radio waves that lead their spins to temporarily align. “Over the next few tens of milliseconds,” Turner noted, “their orientations fan out again, and the magnetization we measure will quickly decrease.”

But what can this tell us about brain activity?

When hemoglobins—the iron-rich oxygen-carrying proteins in our blood—run out of oxygen, Turner explained, “they become paramagnetic,” disturbing the local magnetic field. This makes the protons spin out of phase more rapidly.” One might think this means BOLD fMRI highlights oxygen consumption by ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Tim Vernimmen

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours